Arthrex and JRF Ortho, the oldest and largest fresh graft organization in the world, have helped establish a pathway for advanced cartilage restoration procedures at U.S. Naval Hospital Okinawa, supporting the first successful osteochondral allograft transplantation performed at the facility and expanding access to U.S. service members stationed overseas.
The case, performed by Matthew Henriques, MD (Okinawa, Japan), demonstrates how collaboration among healthcare professionals, industry partners and military medical personnel can help bring advanced treatment options to patients outside the continental United States. By overcoming regulatory, contracting and international shipping challenges, the team successfully delivered fresh donor tissue and specialized instrumentation to Naval Hospital Okinawa located thousands of miles from the continental United States.
Unlike many implants and surgical products, fresh osteochondral allografts are living tissues with a limited transplantation window. Following donor recovery, the tissue must undergo extensive testing for up to 14 days before it can be cleared for use. Once approved, teams have only a short period of time to ensure the graft reaches its destination and is safely transplanted. The complexity – and cost – increases significantly when the destination is an international military base halfway around the world.
"The question became how we could create a pathway for these procedures to support military patients stationed on U.S. bases overseas," said Arthrex Group Product Manager Robert Benedict.
Arthrex and JRF Ortho collaborated with military healthcare personnel to coordinate graft sourcing, logistics and surgical support for the procedure.
While one of the biggest challenges was validating that fresh tissue could reliably reach Okinawa while maintaining viability throughout transit, the fresh graft was ultimately successfully delivered, and the distal tibial allograft case was completed by Dr. Henriques and his team.
"The case went extremely well," Robert said. "They're already scheduling additional procedures and looking for more opportunities to use additional tissues."
Beyond the logistical accomplishment, Biologics and Spine Manager for Arthrex San Diego Cooper Tanquary reflected on the collective impact behind the effort.
"Injuries like these can lead to massive lifestyle changes if not treated appropriately," Cooper said. "Being able to help these patients continue serving their country instead of leaving the military because of a treatable injury is something that's very meaningful for us to be a part of."
